NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

I guess they could have another trial planned with BMS / BMY at MD Anderson in addition to the one planned for UCLA with BMS. But the PR does state 3 different combo treatments for three different cancers in three different trials. Initially I had recently posted I though the other two might be with Merck and another CI - all for recurrent GBM... to see which worked best. However, I made a mistake as it can't be recurrent GBM in all three as they state the cancers will be different.

It's still very possible they all will be with L, but perhaps using L in another indication where the tumor is first removed.